SHELLEY RAUH-GALUSHA: Open Payments
NPI 1386377000 · HENNESSEY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 14 payments from 8 companies in 2025. Trend: 2023 $413 · 2024 $273 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $111 |
| Lundbeck LLC | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| OWP Pharmaceuticals, Inc. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: UBRELVY, REXULTI, QULIPTA, CAPLYTA, KISUNLA, Subvenite, NUZYRA, The Cologuard Plus Collection Kit.
Industry payments across OK — which companies pay providers there.
